RU2010123778A - Процесс - Google Patents
Процесс Download PDFInfo
- Publication number
- RU2010123778A RU2010123778A RU2010123778/04A RU2010123778A RU2010123778A RU 2010123778 A RU2010123778 A RU 2010123778A RU 2010123778/04 A RU2010123778/04 A RU 2010123778/04A RU 2010123778 A RU2010123778 A RU 2010123778A RU 2010123778 A RU2010123778 A RU 2010123778A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- compound
- process according
- thion
- dihydroimidazol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 44
- 150000001875 compounds Chemical class 0.000 claims abstract 43
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 12
- 125000000217 alkyl group Chemical group 0.000 claims abstract 12
- 125000005843 halogen group Chemical group 0.000 claims abstract 12
- 125000003118 aryl group Chemical group 0.000 claims abstract 10
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 claims abstract 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract 4
- 125000003282 alkyl amino group Chemical group 0.000 claims abstract 4
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 4
- 238000006243 chemical reaction Methods 0.000 claims abstract 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract 4
- 229910052731 fluorine Inorganic materials 0.000 claims abstract 4
- 239000011737 fluorine Substances 0.000 claims abstract 4
- 229910052736 halogen Inorganic materials 0.000 claims abstract 4
- 150000002367 halogens Chemical class 0.000 claims abstract 4
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 4
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 claims abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 4
- 125000001624 naphthyl group Chemical group 0.000 claims abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 4
- 230000009466 transformation Effects 0.000 claims abstract 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract 3
- 230000008707 rearrangement Effects 0.000 claims abstract 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000006969 Curtius rearrangement reaction Methods 0.000 claims abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052794 bromium Inorganic materials 0.000 claims abstract 2
- 229910052801 chlorine Inorganic materials 0.000 claims abstract 2
- 239000000460 chlorine Substances 0.000 claims abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract 2
- 229910052740 iodine Inorganic materials 0.000 claims abstract 2
- 239000011630 iodine Substances 0.000 claims abstract 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims 5
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 3
- CWWWTTYMUOYSQA-LLVKDONJSA-N 4-(2-aminoethyl)-3-[(3r)-6,8-difluoro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC(F)=CC(F)=C2OC1 CWWWTTYMUOYSQA-LLVKDONJSA-N 0.000 claims 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000002346 iodo group Chemical group I* 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims 1
- CIZSXHJFJOUTBA-CYBMUJFWSA-N 3-[(3r)-3,4-dihydro-2h-chromen-3-yl]-4-[2-(methylamino)ethyl]-1h-imidazole-2-thione Chemical compound CNCCC1=CNC(=S)N1[C@@H]1CC2=CC=CC=C2OC1 CIZSXHJFJOUTBA-CYBMUJFWSA-N 0.000 claims 1
- GFTROSXKPGWDQY-GFCCVEGCSA-N 3-[(3r)-6,8-difluoro-3,4-dihydro-2h-chromen-3-yl]-4-[2-(methylamino)ethyl]-1h-imidazole-2-thione Chemical compound CNCCC1=CNC(=S)N1[C@@H]1CC2=CC(F)=CC(F)=C2OC1 GFTROSXKPGWDQY-GFCCVEGCSA-N 0.000 claims 1
- FDILNPIPLDMEKH-GFCCVEGCSA-N 3-[(3r)-6-hydroxy-3,4-dihydro-2h-chromen-3-yl]-4-[2-(methylamino)ethyl]-1h-imidazole-2-thione Chemical compound CNCCC1=CNC(=S)N1[C@@H]1CC2=CC(O)=CC=C2OC1 FDILNPIPLDMEKH-GFCCVEGCSA-N 0.000 claims 1
- VHYPBFDDZNKESQ-GFCCVEGCSA-N 4-(2-aminoethyl)-3-[(3r)-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC=CC=C2OC1 VHYPBFDDZNKESQ-GFCCVEGCSA-N 0.000 claims 1
- JBMQYQOWXZAPDM-SECBINFHSA-N 4-(2-aminoethyl)-3-[(3r)-6,7,8-trifluoro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC(C=C(F)C(F)=C2F)=C2OC1 JBMQYQOWXZAPDM-SECBINFHSA-N 0.000 claims 1
- DZRNOQCTKOBUAK-SNVBAGLBSA-N 4-(2-aminoethyl)-3-[(3r)-6,7-difluoro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC(F)=C(F)C=C2OC1 DZRNOQCTKOBUAK-SNVBAGLBSA-N 0.000 claims 1
- IACPBROODVYPRT-GFCCVEGCSA-N 4-(2-aminoethyl)-3-[(3r)-6-chloro-8-methoxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound N1([C@@H]2CC=3C=C(Cl)C=C(C=3OC2)OC)C(CCN)=CNC1=S IACPBROODVYPRT-GFCCVEGCSA-N 0.000 claims 1
- ZVNPVFPANOYSGK-GFCCVEGCSA-N 4-(2-aminoethyl)-3-[(3r)-6-fluoro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC(F)=CC=C2OC1 ZVNPVFPANOYSGK-GFCCVEGCSA-N 0.000 claims 1
- LYOMOBDZZKIPDC-LLVKDONJSA-N 4-(2-aminoethyl)-3-[(3r)-6-hydroxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC(O)=CC=C2OC1 LYOMOBDZZKIPDC-LLVKDONJSA-N 0.000 claims 1
- RUDRRZIQZRQSRL-GFCCVEGCSA-N 4-(2-aminoethyl)-3-[(3r)-6-methoxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound N1([C@H]2COC3=CC=C(C=C3C2)OC)C(CCN)=CNC1=S RUDRRZIQZRQSRL-GFCCVEGCSA-N 0.000 claims 1
- RWBYHVOPHRDVAI-GFCCVEGCSA-N 4-(2-aminoethyl)-3-[(3r)-6-nitro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC([N+]([O-])=O)=CC=C2OC1 RWBYHVOPHRDVAI-GFCCVEGCSA-N 0.000 claims 1
- GYMJLUMPHLFEKV-GOSISDBHSA-N 4-(2-aminoethyl)-3-[(3r)-7-benzyl-6-hydroxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC(O)=C(CC=3C=CC=CC=3)C=C2OC1 GYMJLUMPHLFEKV-GOSISDBHSA-N 0.000 claims 1
- ZLRRWMLDYDBHEB-LLVKDONJSA-N 4-(2-aminoethyl)-3-[(3r)-8-chloro-6-methoxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound N1([C@H]2COC3=C(Cl)C=C(C=C3C2)OC)C(CCN)=CNC1=S ZLRRWMLDYDBHEB-LLVKDONJSA-N 0.000 claims 1
- XRNOJLDIRCCQPD-LLVKDONJSA-N 4-(2-aminoethyl)-3-[(3r)-8-fluoro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC=CC(F)=C2OC1 XRNOJLDIRCCQPD-LLVKDONJSA-N 0.000 claims 1
- TXJFZUNUABXLTG-LLVKDONJSA-N 4-(2-aminoethyl)-3-[(3r)-8-hydroxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC2=CC=CC(O)=C2OC1 TXJFZUNUABXLTG-LLVKDONJSA-N 0.000 claims 1
- MIUACEHSFFFAPE-GFCCVEGCSA-N 4-(2-aminoethyl)-3-[(3r)-8-methoxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound N1([C@@H]2CC=3C=CC=C(C=3OC2)OC)C(CCN)=CNC1=S MIUACEHSFFFAPE-GFCCVEGCSA-N 0.000 claims 1
- FNPSIDQPVWLMAI-LLVKDONJSA-N 4-(2-aminoethyl)-3-[(3r)-8-nitro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCCC1=CNC(=S)N1[C@@H]1CC(C=CC=C2[N+]([O-])=O)=C2OC1 FNPSIDQPVWLMAI-LLVKDONJSA-N 0.000 claims 1
- OQDLAKHVUUXKNL-SNVBAGLBSA-N 4-(aminomethyl)-3-[(3r)-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCC1=CNC(=S)N1[C@@H]1CC2=CC=CC=C2OC1 OQDLAKHVUUXKNL-SNVBAGLBSA-N 0.000 claims 1
- GHNQCWKGQHAFDS-SECBINFHSA-N 4-(aminomethyl)-3-[(3r)-6,8-difluoro-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCC1=CNC(=S)N1[C@@H]1CC2=CC(F)=CC(F)=C2OC1 GHNQCWKGQHAFDS-SECBINFHSA-N 0.000 claims 1
- XIDMCXLNSQNAPP-SECBINFHSA-N 4-(aminomethyl)-3-[(3r)-6-hydroxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound NCC1=CNC(=S)N1[C@@H]1CC2=CC(O)=CC=C2OC1 XIDMCXLNSQNAPP-SECBINFHSA-N 0.000 claims 1
- INYLGVJSDTUSNC-GOSISDBHSA-N 4-[2-(benzylamino)ethyl]-3-[(3r)-6-hydroxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound C=1NC(=S)N([C@H]2COC3=CC=C(C=C3C2)O)C=1CCNCC1=CC=CC=C1 INYLGVJSDTUSNC-GOSISDBHSA-N 0.000 claims 1
- AMHOPCZYGXZAKW-LJQANCHMSA-N 4-[2-(benzylamino)ethyl]-3-[(3r)-6-methoxy-3,4-dihydro-2h-chromen-3-yl]-1h-imidazole-2-thione Chemical compound C=1NC(=S)N([C@H]2COC3=CC=C(C=C3C2)OC)C=1CCNCC1=CC=CC=C1 AMHOPCZYGXZAKW-LJQANCHMSA-N 0.000 claims 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims 1
- 125000003368 amide group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- 239000013067 intermediate product Substances 0.000 claims 1
- SIHRNZKSJPIRJH-CQSZACIVSA-N n-[(3r)-3-[4-(2-aminoethyl)-2-sulfanylidene-1h-imidazol-3-yl]-3,4-dihydro-2h-chromen-6-yl]acetamide Chemical compound N1([C@H]2COC3=CC=C(C=C3C2)NC(=O)C)C(CCN)=CNC1=S SIHRNZKSJPIRJH-CQSZACIVSA-N 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 125000005544 phthalimido group Chemical group 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000001953 recrystallisation Methods 0.000 claims 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98746707P | 2007-11-13 | 2007-11-13 | |
| US60/987,467 | 2007-11-13 | ||
| US8592708P | 2008-08-04 | 2008-08-04 | |
| US61/085,927 | 2008-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010123778A true RU2010123778A (ru) | 2011-12-20 |
Family
ID=40550012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010123778/04A RU2010123778A (ru) | 2007-11-13 | 2008-11-13 | Процесс |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100298580A1 (enExample) |
| EP (1) | EP2217585A2 (enExample) |
| JP (1) | JP2011503175A (enExample) |
| KR (1) | KR20100102606A (enExample) |
| CN (1) | CN101952271A (enExample) |
| AR (1) | AR069311A1 (enExample) |
| AU (1) | AU2008321625A1 (enExample) |
| BR (1) | BRPI0818105A2 (enExample) |
| CA (1) | CA2705512A1 (enExample) |
| MX (1) | MX2010005193A (enExample) |
| RU (1) | RU2010123778A (enExample) |
| TW (1) | TW200927740A (enExample) |
| WO (1) | WO2009064210A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201316410D0 (en) * | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
| US11875700B2 (en) | 2014-05-20 | 2024-01-16 | Jessica Robinson | Systems and methods for providing communication services |
| CN110590728B (zh) * | 2019-10-15 | 2022-03-22 | 青岛科技大学 | 一种多取代4-苯基色满类化合物的合成方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0232279B2 (ja) * | 1982-08-12 | 1990-07-19 | Kowa Co | Jihidorobenzopiranjioorunoseiho |
| SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
| FI20040310A7 (fi) * | 1994-04-26 | 2004-02-27 | Syntex Inc | Menetelmä bentsosykloalkyyliatsolitionijohdannaisten valmistamiseksi |
| US6867224B2 (en) * | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| JP2004075614A (ja) * | 2002-08-20 | 2004-03-11 | Sankyo Co Ltd | クロメン誘導体を含有する医薬 |
| US7125904B2 (en) * | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
| US7456214B2 (en) * | 2004-05-03 | 2008-11-25 | Baylor University | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
| US20050245489A1 (en) * | 2004-05-03 | 2005-11-03 | Pinney Kevin G | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
| WO2006012135A1 (en) * | 2004-06-24 | 2006-02-02 | Janssen Pharmaceutica, N. V. | Quaternary salt ccr2 antagonists |
| KR20130028988A (ko) * | 2004-10-14 | 2013-03-20 | 애보트 게엠베하 운트 콤파니 카게 | 도파민 ｄ3 수용체의 조절에 반응하는 장애를 치료하기에 적합한 아릴설포닐메틸 또는 아릴설폰아미드 치환된 방향족 화합물 |
| KR20080074220A (ko) * | 2005-12-08 | 2008-08-12 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 키나아제 억제 활성을 갖는 비시클릭 화합물 |
| ES2483718T3 (es) * | 2006-12-12 | 2014-08-07 | Bial-Portela & Ca, S.A. | Proceso catalítico para hidrogenación asimétrica |
-
2008
- 2008-11-12 TW TW097143774A patent/TW200927740A/zh unknown
- 2008-11-13 WO PCT/PT2008/000048 patent/WO2009064210A2/en not_active Ceased
- 2008-11-13 AR ARP080104958A patent/AR069311A1/es unknown
- 2008-11-13 KR KR1020107012805A patent/KR20100102606A/ko not_active Withdrawn
- 2008-11-13 BR BRPI0818105A patent/BRPI0818105A2/pt not_active IP Right Cessation
- 2008-11-13 AU AU2008321625A patent/AU2008321625A1/en not_active Abandoned
- 2008-11-13 JP JP2010533987A patent/JP2011503175A/ja active Pending
- 2008-11-13 CN CN2008801246552A patent/CN101952271A/zh active Pending
- 2008-11-13 US US12/742,738 patent/US20100298580A1/en not_active Abandoned
- 2008-11-13 MX MX2010005193A patent/MX2010005193A/es not_active Application Discontinuation
- 2008-11-13 RU RU2010123778/04A patent/RU2010123778A/ru unknown
- 2008-11-13 CA CA2705512A patent/CA2705512A1/en not_active Abandoned
- 2008-11-13 EP EP08850447A patent/EP2217585A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2217585A2 (en) | 2010-08-18 |
| US20100298580A1 (en) | 2010-11-25 |
| MX2010005193A (es) | 2010-06-02 |
| AU2008321625A1 (en) | 2009-05-22 |
| BRPI0818105A2 (pt) | 2019-09-24 |
| CN101952271A (zh) | 2011-01-19 |
| AR069311A1 (es) | 2010-01-13 |
| KR20100102606A (ko) | 2010-09-24 |
| WO2009064210A3 (en) | 2009-12-30 |
| JP2011503175A (ja) | 2011-01-27 |
| WO2009064210A2 (en) | 2009-05-22 |
| CA2705512A1 (en) | 2009-05-22 |
| TW200927740A (en) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018131134A (ru) | ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ КАК ИНГИБИТОРЫ ТРК КИНАЗЫ | |
| RU2011133749A (ru) | Способ получения и выделения 2-ациламино-3-дифенилпропионовой кислоты | |
| EA201290401A1 (ru) | Азотсодержащее гетероциклическое соединение и сельскохозяйственный фунгицид | |
| EA200901652A1 (ru) | Способ получения дифторметилзамещённых пиразоловых соединений | |
| CA2608099A1 (en) | Dipyridyl-dihydropyrazolones and their use | |
| DK1678119T3 (da) | Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere | |
| EA201070872A1 (ru) | Производные азабициклических карбоксамидов, их получение и их применение в терапии | |
| RU2010106393A (ru) | Новые микробиоциды | |
| RU2011117028A (ru) | Ингибиторы глюкозилцерамидсинтазы 2-ациламинопропанольного типа | |
| RU2010101004A (ru) | Новые микробиоциды | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| RU2006135120A (ru) | Производные пирролопиримидина | |
| MX2010003148A (es) | Procedimiento para la preparacion de diamidas de acido sulfonico. | |
| RU2011100815A (ru) | Способ получения каспофунгина и его промежуточных соединений | |
| PH12012502363A1 (en) | Process for the preparation of dihydropyrrole derivatives | |
| BRPI0408160B1 (pt) | Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo | |
| BRPI0409049A (pt) | métodos de preparação de um composto, composição e composição cristalina | |
| RU2013137751A (ru) | Способ получения гиразы и ингибиторов топоизомеразы | |
| EA200500717A1 (ru) | Новые соединения имидазопиридина, способ их получения и фармацевтические композиции, которые их содержат | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| RU2010123778A (ru) | Процесс | |
| JP2011503175A5 (enExample) | ||
| EA200800633A1 (ru) | Способ получения производных сартана и промежуточных соединений, пригодных для этого способа | |
| CO6331466A2 (es) | Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion y su aplicacion en terapeutica | |
| RU2012154338A (ru) | Производные 6-метил-4-фенил-5-(фенил или циклоалкил)-карбамоил-1,2,3,4-тетрагидропиримидин-2-она в качестве противотуберкулезных средств |